KCAS Bio is proud to announce that its EU site (Lyon, France) has successfully renewed its Statement of Compliance with Good Laboratory Practices (GLP), confirming its ability to deliver GLP-grade bioanalytical methods in support of preclinical studies.
Our GLP test facility was granted a Level of compliance “A”, reinforcing KCAS Bio’s capability to support critical investigational new drug (IND)-enabling programs. This renewal provides sponsors with continued confidence that their studies are supported by robust, compliant, and regulatory-ready bioanalytical data.
This GLP renewal, combined with our ISO 9001:2015 certification consistently maintained for over 15 years, reflects the rigor, reliability, and consistency applied by our scientific teams at the Lyon site across all projects. KCAS Bio supports studies in a wide range of preclinical species, including mouse, rat, rabbit, dog, minipig, and non-human primates (marmoset and cynomolgus monkey), and across multiple modalities, including large molecules, biologics, small molecules, cell and gene therapies, vaccines, and oligonucleotides.
Our continued commitment to quality enables our teams to generate data that sponsors can confidently rely on to support sound decision-making throughout preclinical development.
Interested in getting in touch? Please fill out the form below!